Pure Global AI
NCT06405776Recruiting

Effect of Lidocaine on Postoperative Pain and Long-term Survival in Elderly Patients Undergoing Colorectal Surgery

Effect of Perioperative Continuous Intravenous Infusion of Lidocaine on Postoperative Pain and Long-term Survival in Elderly Patients Undergoing Colorectal Cancer Surgery: a Prospective, Randomized Controlled Trial
West China HospitalClinicalTrials.govdrug
Verified
Study focus
Disease/Condition
Colorectal Cancer
Drug/Device/Intervention
lidocaine
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
West China Hospital
Location
Sichuan, China
Timeline & enrollment
Phase
N/A
Start date
Jun 05, 2023
End date
Jun 01, 2027
Enrollment
276 participants
Primary outcome

The incidence of chronic pain at 3 months postoperatively

Summary

This study is a further observation and follow-up of the patients enrolled in the
 registration number NCT05920980 to further evaluate the effect of long-term infusion of
 lidocaine on postoperative chronic pain, long-term quality of life and survival rate in
 patients undergoing colorectal cancer surgery.

ICD-10 classifications
Malignant neoplasm of colonMalignant neoplasm: Descending colonMalignant neoplasm: Colon, unspecifiedMalignant neoplasm: Ascending colonMalignant neoplasm: Overlapping lesion of colon
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06405776
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06405776 through Pure Global AI's free database. This phase not specified trial is sponsored by West China Hospital and is currently Recruiting. The study focuses on Colorectal Cancer. Target enrollment is 276 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.